home
about cancer
bioven
the latest
contact us
about cancer
cancer overview
|
cancer treatments
|
products
|
resources & journals
resources & journals
Cancer Resources and Journals
Find the most relevant cancer information through our network of website resources and journals.
Medical News Online. 2008 -
Seeking Funding for Cancer Vaccine Trial and Fast Track Commercialisation.
http://www.medicalnewstoday.com/articles/93337.php
(accessed January 9, 2008)
Woodman, R. 2007 -
Roche Cuts Tarceva Price by 27.5% in Britain Pending NICE Review.
APM Health Europe
http://apmhealtheurope.com/story.php?mots=NSCLC&searchScope=1&searchType=0&numero=L8437
(accessed January 4, 2008)
Medicine World. 2006 -
FDA Approves Tarceva for the Treatment of NSCLC.
http://medicineworld.org/cancer/lead/tarceva-approved.html
(accessed January 4, 2008)
Tarceva.com. 2007 -
Tarceva: Survival Results.
http://www.tarceva.com/professional/survival/results.jsp
(accessed January 4, 2008)
Provengenow.org. 2007 -
Immunotherapy
http://www.provengenow.org/immunotherapy.html
(accessed January 4, 2008)
PharmaAsia.com. 2006 2007 -
Malaysia’s BIOVEN Makes Headway in Cancer Vaccine.
http://www.pharmaasia.com/print.asp?id=6652
Gastroenterology 2003; 124(5): 1337-47 -
Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.
Authors:
DJ Marciniak, L Moragoda, RM Mohammad, Y Yu, KK Nagothu, A Aboukameel, FH Sarkar, VN Adsay, AK Rishi, and AP Majumdar
International Journal of Cancer, October 1 2002, 101(4):390-394 -
Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer
Authors:
Christine Solbach, Marc Roller, Andre Ahr, Sibylle Loibl, Maria Nicoletti, Manfred Stegmueller, Hans-Georg Kreysch, Rainald Knecht, Manfred Kaufmann
Cancer Research, July 1, 2001, 61:5090-5101 -
Acquired Resistance to the Antitumor Effect of Epidermal Growth Factor Receptor-blocking Antibodies in Vivo: A Role for Altered Tumor Angiogenesis.
Authors:
Alicia Viloria-Petit, Tania Crombet, Serge Jothy, Daniel Hicklin, Peter Bohlen, Jean Marc Schlaeppi, Janusz Rak and Robert S. Kerbel
latest news
View RSS feed
announcements
World Vaccine Congress Asia 2010
read more>